17th November 2025, marked our Day 1 of the Roche–MoH–SHA MOU Implementation Workshop at the Great Rift Valley Lodge with a high-level opening plenary bringing together leadership from the Ministry of Health, NCI–Kenya, the Social Health Authority (SHA), KEMSA, the Digital Health Authority (DHA), the MoH Division of Health Products & Technologies (DHPT), Roche, and Savannah Global Health Institute (SGHI). The day set a unified tone for strengthening Kenya’s national architecture for breast and cervical cancer control.
Sessions highlighted the current state of breast and cervical cancer in Kenya, reviewing epidemiological trends and the health system burden. Partners explored the investment case for oncology in Africa, followed by a review of health financing achievements and challenges from the previous MOU—now reframed within SHA’s expanded mandate and DHA’s emerging digital ecosystem for claims, approvals, and health data integration.
KEMSA and DHPT shared key lessons from past collaborations in supply chain optimisation, commodity access, and regulatory alignment, while Roche provided insights on partnerships for access to innovation. SGHI contributed perspectives on systems strengthening, implementation support, and global standards that can fortify national cancer pathways.
The afternoon was dedicated to a deep-dive workshop to co-develop clear Terms of Reference and KPIs for the new MOU. Stakeholders identified actionable priorities in screening, diagnostics, treatment access, sample referral systems, supply chain efficiency, digital health integration, and sustainable financing across all levels of care.
Day 1 concluded with a consolidation of emerging priorities and agreement on action points, establishing a strong foundation for the technical workstreams scheduled for Day 2.
Leave a Reply